COMMON STOCK AND PREFERRED STOCK	9 Months Ended
May 31, 2013
Equity [Abstract]
COMMON STOCK AND PREFERRED STOCK	NOTE 6 – COMMON STOCK AND PREFERRED STOCK The Company effected a reverse split on the basis of one new share for each one thousand shares held (1:1000) which was approved by FINRA on October 27, 2014 and is retroactively impacted to the share and per share data contained herein. Concurrently the Company increased the authorized share capital from 300,0000,000 to 520,000,000 shares. The Company has authorized 520,000,000 shares, of which 500 million shares are authorized as common stock and 20 million shares are authorized as preferred stock, of which a total of 3,000 shares have been designated Series A Preferred Stock carrying super voting rights of 200:1 as to each share of common stock and convertible into shares of common stock at a ratio of 200 common shares for each one share of Series A preferred stock. On January 17, 2013, the Board of Directors of the Company authorized the issuance of 27,500 common shares of the Company's stock to Dr. Larry Eastland, the sole director and officer of the Company, for his services at $6 per share. As at May 31, 2013 and August 31, 2012 there were 297,337 and 269,837 shares of common stock issued and outstanding, respectively. As at May 31, 2013 and August 31, 2012 there were Nil shares of Series A Preferred Stock issued and outstanding.

COMMON STOCK AND PREFERRED STOCK

9 Months Ended

May 31, 2013

NOTE 6 – COMMON STOCK AND PREFERRED STOCK

The Company effected a reverse split on the basis of one new share for each one thousand shares held (1:1000) which was approved by FINRA on October 27, 2014 and is retroactively impacted to the share and per share data contained herein.

Concurrently the Company increased the authorized share capital from 300,0000,000 to 520,000,000 shares. The Company has authorized 520,000,000 shares, of which 500 million shares are authorized as common stock and 20 million shares are authorized as preferred stock, of which a total of 3,000 shares have been designated Series A Preferred Stock carrying super voting rights of 200:1 as to each share of common stock and convertible into shares of common stock at a ratio of 200 common shares for each one share of Series A preferred stock.

On January 17, 2013, the Board of Directors of the Company authorized the issuance of 27,500 common shares of the Company's stock to Dr. Larry Eastland, the sole director and officer of the Company, for his services at $6 per share.

As at May 31, 2013 and August 31, 2012 there were 297,337 and 269,837 shares of common stock issued and outstanding, respectively. As at May 31, 2013 and August 31, 2012 there were Nil shares of Series A Preferred Stock issued and outstanding.

Willow Creek Enterprises Inc. 10-Q